Register entry
- Registered sites
- 0
- Active NDC listings
- 18
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1818 active NDC listings: 18 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 18.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 14 |
| tablet, film coated, extended release | 4 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| janssen ortho llc | 14 |
| janssen ortho llc | 4 |
Catalogue
Marketed products
18| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Cetirizine Hydrochloride | tablet, film coated | 17314-705DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | tablet, film coated | 17314-737DRUG FOR FURTHER PROCESSING |
| - | apalutamide | tablet, film coated | 17314-215DRUG FOR FURTHER PROCESSING |
| - | canagliflozin | tablet, film coated | 17314-575DRUG FOR FURTHER PROCESSING |
| - | canagliflozin | tablet, film coated | 17314-577DRUG FOR FURTHER PROCESSING |
| - | canagliflozin and metformin hydrochloride | tablet, film coated | 17314-315DRUG FOR FURTHER PROCESSING |
| - | canagliflozin and metformin hydrochloride | tablet, film coated | 17314-317DRUG FOR FURTHER PROCESSING |
| - | canagliflozin and metformin hydrochloride | tablet, film coated | 17314-320DRUG FOR FURTHER PROCESSING |
| - | canagliflozin and metformin hydrochloride | tablet, film coated | 17314-322DRUG FOR FURTHER PROCESSING |
| - | canagliflozin and metformin hydrochloride | tablet, film coated, extended release | 17314-515DRUG FOR FURTHER PROCESSING |
| - | canagliflozin and metformin hydrochloride | tablet, film coated, extended release | 17314-517DRUG FOR FURTHER PROCESSING |
| - | canagliflozin and metformin hydrochloride | tablet, film coated, extended release | 17314-520DRUG FOR FURTHER PROCESSING |
| - | canagliflozin and metformin hydrochloride | tablet, film coated, extended release | 17314-522DRUG FOR FURTHER PROCESSING |
| - | darunavir ethanolate | tablet, film coated | 17314-603DRUG FOR FURTHER PROCESSING |
| - | darunavir ethanolate | tablet, film coated | 17314-605DRUG FOR FURTHER PROCESSING |
| - | darunavir ethanolate | tablet, film coated | 17314-607DRUG FOR FURTHER PROCESSING |
| - | darunavir ethanolate | tablet, film coated | 17314-609DRUG FOR FURTHER PROCESSING |
| - | darunavir ethanolate and cobicistat | tablet, film coated | 17314-812DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing canagliflozin and metformin hydrochloride
- Janssen Pharmaceuticals, Inc.0 sites · 149 NDC
Enquiry
Common questions
- Is Janssen Ortho LLC FDA approved?
- Janssen Ortho LLC holds no registered establishment of its own; 18 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Janssen Ortho LLC make?
- 18 products are listed under Janssen Ortho LLC in the openFDA NDC Directory, most often as tablet, film coated; tablet, film coated, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.